Choi GH - Search Results

1

Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.

Kim GA, Han S, Choi GH, Choi J, Lim YS. Kim GA, et al. Among authors: choi j, choi gh. Aliment Pharmacol Ther. 2020 Jun;51(11):1169-1179. doi: 10.1111/apt.15725. Epub 2020 Apr 14. Aliment Pharmacol Ther. 2020. PMID: 32291781

2

Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses.

Choi GH, Shim JH, Kim MJ, Ryu MH, Ryoo BY, Kang YK, Shin YM, Kim KM, Lim YS, Lee HC. Choi GH, et al. Radiology. 2013 Nov;269(2):603-11. doi: 10.1148/radiol.13130150. Epub 2013 Jul 17. Radiology. 2013. PMID: 23864102

3

Prognostic Scoring Models for Patients Undergoing Sorafenib Treatment for Advanced Stage Hepatocellular Carcinoma in Real-Life Practice.

Choi GH, Han S, Shim JH, Ryu MH, Ryoo BY, Kang YK, Kim KM, Lim YS, Lee HC. Choi GH, et al. Am J Clin Oncol. 2017 Apr;40(2):167-174. doi: 10.1097/COC.0000000000000132. Am J Clin Oncol. 2017. PMID: 25268070

4

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.

Na SK, Choi GH, Lee HC, Shin YM, An J, Lee D, Shim JH, Kim KM, Lim YS, Chung YH, Lee YS. Na SK, et al. Among authors: choi gh. PLoS One. 2018 Jun 7;13(6):e0198138. doi: 10.1371/journal.pone.0198138. eCollection 2018. PLoS One. 2018. PMID: 29879137 Free PMC article.

5

Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.

Choi J, Choi GH, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS, Kim KM. Choi J, et al. Among authors: choi gh. Liver Int. 2019 May;39(5):985-994. doi: 10.1111/liv.14082. Epub 2019 Mar 25. Liver Int. 2019. PMID: 30821090

6

High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.

Choi GH, Kim GA, Choi J, Han S, Lim YS. Choi GH, et al. Among authors: choi j. Aliment Pharmacol Ther. 2019 Jul;50(2):215-226. doi: 10.1111/apt.15311. Epub 2019 May 28. Aliment Pharmacol Ther. 2019. PMID: 31135074

7

Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply.

Choi GH, Lim YS. Choi GH, et al. Aliment Pharmacol Ther. 2019 Sep;50(5):619-620. doi: 10.1111/apt.15451. Aliment Pharmacol Ther. 2019. PMID: 31414529 No abstract available.

8

A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea.

Choi GH, Jang ES, Kim JW, Jeong SH. Choi GH, et al. Gut Liver. 2020 Nov 15;14(6):808-816. doi: 10.5009/gnl19296. Gut Liver. 2020. PMID: 32066209 Free PMC article.

9

The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma.

Choi K, Jang HY, Ahn JM, Hwang SH, Chung JW, Choi YS, Kim JW, Jang ES, Choi GH, Jeong SH. Choi K, et al. Among authors: choi ys, choi gh. Clin Mol Hepatol. 2020 Oct;26(4):492-505. doi: 10.3350/cmh.2020.0005. Epub 2020 Jul 10. Clin Mol Hepatol. 2020. PMID: 32646201 Free PMC article.

10

Development of machine learning-based clinical decision support system for hepatocellular carcinoma.

Choi GH, Yun J, Choi J, Lee D, Shim JH, Lee HC, Chung YH, Lee YS, Park B, Kim N, Kim KM. Choi GH, et al. Among authors: choi j. Sci Rep. 2020 Sep 9;10(1):14855. doi: 10.1038/s41598-020-71796-z. Sci Rep. 2020. PMID: 32908183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters